CD4+CD25+CD127− assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects-Reference-Cited by-同舟云学术

CD4+CD25+CD127− assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects

Published:2012-09-27 Issue:1 Volume:84B Page:50-54
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Saison Julien,Demaret Julie,Venet Fabienne,Chidiac Christian,Malcus Christophe,Poitevin-Later Francoise,Tardy Jean-Claude,Ferry Tristan,Monneret Guillaume

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference22 articles.

1. Coordination of early protective immunity to viral infection by regulatory T cells;Lund;Science,2008

2. Natural tregs and persistent viral infections;Li;J Virol,2008

3. Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIVinfected individuals;Kinter;Proc Natl Acad Sci USA,2007

4. CD25_ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8_ T cells in vitro;Kinter;AIDS Res Hum Retroviruses,2007

5. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers;Shaw;J Virol,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting T regulatory (T_reg) cells in immunotherapy-resistant cancers;Cancer Drug Resistance;2024-01-12

2. Interaction of peripheral CD4+CD25+CD127− Tregs with prolactin in HCV hepatocellular carcinoma: oncogenic or immunogenic mechanisms;Egyptian Liver Journal;2023-04-03

3. Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles;Frontiers in Immunology;2021-05-25

4. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs;Frontiers in Immunology;2021-03-31

5. The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients;Translational Oncology;2020-12